Detecting low level sequence variants in recombinant monoclonal antibodies.
A systematic analytical approach combining tryptic and chymotryptic peptide mapping with a Mascot Error Tolerant Search (ETS) has been developed to detect and identify low level protein sequence variants, i.e., amino acid substitutions, in recombinant monoclonal antibodies. The reversed-phase HPLC separation with ultraviolet (UV) detection and mass spectral acquisition parameters of the peptide mapping methods were optimized by using a series of model samples that contained low levels (0.5-5.0%) of recombinant humanized anti-HER2 antibody (rhumAb HER2) along with another unrelated recombinant humanized monoclonal antibody (rhumAb A). This systematic approach's application in protein sequence variant analysis depends upon time and sensitivity constraints. An example of using this approach as a rapid screening assay is described in the first case study. For stable CHO clone selection for an early stage antibody project, comparison of peptide map UV profiles from the top four clone-derived rhumAb B samples quickly detected two sequence variants (M83R at 5% and P274T at 42% protein levels) from two clones among the four. The second case study described in this work demonstrates how this approach can be applied to late stage antibody projects. A sequence variant, L413Q, present at 0.3% relative to the expected sequence of rhumAb C was identified by a Mascot-ETS for one out of four top producers. The incorporation of this systematic sequence variant analysis into clone selection and the peptide mapping procedure described herein have practical applications for the biotechnology industry, including possible detection of polymorphisms in endogenous proteins.
Yang
Yi
Y
Protein Analytical Chemistry, Genentech, Inc., South San Francisco, CA, USA.
Strahan
Alex
A
Li
Charlene
C
Shen
Amy
A
Liu
Hongbin
H
Ouyang
Jun
J
Katta
Viswanatham
V
Francissen
Kathleen
K
Zhang
Boyan
B
D000595:Amino Acid Sequence; D000818:Animals; D000911:Antibodies, Monoclonal / Q000737:chemistry*; D016466:CHO Cells; D002851:Chromatography, High Pressure Liquid; D006224:Cricetinae; D003412:Cricetulus; D006801:Humans; D013058:Mass Spectrometry; D008969:Molecular Sequence Data; D010449:Peptide Mapping / Q000379:methods*; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000276:immunology; D011994:Recombinant Proteins / Q000737:chemistry; D012680:Sensitivity and Specificity; D014466:Ultraviolet Rays
D000911:Antibodies, Monoclonal; D018719:Erb-b2 Receptor Tyrosine Kinases; D011994:Recombinant Proteins; C508053:ERBB2 protein, human
Org Lett. 2002 Jan 24;4(2):165-8
11796041
Mass Spectrom Rev. 2005 Jul-Aug;24(4):508-48
15389847
Hum Mutat. 2000;15(1):7-12
10612815
Protein Sci. 1998 Feb;7(2):500-3
9521127
Protein Expr Purif. 2003 Feb;27(2):365-74
12597898
Anal Chem. 2006 Sep 15;78(18):6645-50
16970346
Biochem Biophys Res Commun. 1995 Jun 6;211(1):40-8
7779107
Proc Natl Acad Sci U S A. 1992 May 15;89(10):4285-9
1350088
J Mass Spectrom. 1996 Oct;31(10):1185-7
8916427
MAbs. 2009 Jul-Aug;1(4):332-8
20073133
J Biol Chem. 1997 Nov 14;272(46):28980-8
9360970
J Biol Chem. 2009 Nov 20;284(47):32686-94
19783658
J Biol Chem. 1989 Jan 5;264(1):531-9
2642478
Biochem Biophys Res Commun. 1988 Oct 31;156(2):733-9
3056402
Anal Chem. 2000 Feb 15;72(4):757-63
10701260
Mol Cell Proteomics. 2004 Jun;3(6):608-14
15034119
Protein Expr Purif. 1993 Oct;4(5):465-72
7504538
J Chromatogr B Analyt Technol Biomed Life Sci. 2006 Sep 1;841(1-2):110-22
16872917
Anal Chem. 2009 Nov 15;81(22):9282-90
19852494
Biotechnol Bioeng. 1999 Feb 20;62(4):485-8
9921157
J Pharm Biomed Anal. 2008 Jun 9;47(2):285-94
18313251
Immunol Lett. 2007 Jul 31;111(1):66-8
17583358
Proteomics. 2002 Oct;2(10):1426-34
12422359
Biochem Biophys Res Commun. 1988 Aug 30;155(1):518-23
3137938
Mol Cell Biol. 1984 Oct;4(10):1951-60
6095032
J Am Soc Mass Spectrom. 2007 Jun;18(6):1070-9
17446085
Biotechnology (N Y). 1993 Nov;11(11):1293-7
7764191
Anal Chem. 2008 Apr 1;80(7):2379-90
18307322